Aetna (AET) Tops Q3 EPS by 13c; Guides FY15 EPS In-Line

Aetna (NYSE: AET) reported Q3 EPS of $1.90, $0.13 better than the analyst estimate of $1.77. Revenue for the quarter came in at $15 billion versus the consensus estimate of $15.22 billion.

Aetna sees FY2015 EPS of $7.45-$7.55, versus the consensus of $7.53.

“Aetna delivered another quarter of strong results, continuing our momentum from the first half of the year,” said Mark T. Bertolini, Aetna chairman and CEO. “Based on these results, we are raising our projection on full-year 2015 operating earnings per share for the fourth time this year to a range of $7.45 to $7.55 per share from our prior projection of at least $7.40 per share.

“As we finish out the year and look toward 2016 and beyond, we are well-positioned across a number of major growth opportunities, including Medicare and Medicaid. We continue to work diligently on planning for the Humana integration, and we are excited about the value that the combination will create for consumers and shareholders,” said Bertolini.

“We are quite pleased with our third-quarter results, which continue to be supported by strong cash flow and operating margins,” said Shawn M. Guertin, Aetna executive vice president and CFO. “Our strong underwriting results benefited from disciplined pricing and continued moderate medical cost trends.

“We’re also pleased with the continued successful execution of our growth strategy, which will be enhanced by our proposed acquisition of Humana,” said Guertin.

For earnings history and earnings-related data on Aetna (AET) click here.

You May Also Be Interested In

• Hasbro (HAS) brand strength sees earnings top expectations
• Capitol Federal Financial (CFFN) Misses Q2 EPS by 1c
• Norfolk Southern (NSC) Misses Q1 EPS by 12c